Value of monocyte distribution width for predicting severe cholecystitis: a retrospective cohort study

Objectives: Acute cholecystitis is a gallbladder inflammation, and the Tokyo Guidelines 2018 (TG18) can be used to predict its presence and severity with high sensitivity and specificity. However, TG18 grading require the collection of excessive parameters. Monocyte distribution width (MDW) is a parameter used to detect sepsis early. Therefore, we investigated the correlation betweenMDWand cholecystitis severity. Methods: We conducted a retrospective study of patients with cholecystitis admitted to our hospital from November 1, 2020, to August 31, 2021. The primary outcome was severe cholecystitis analyzed as a composite of intensive care unit (ICU) admission and mortality. The secondary outcomes were length of hospital stay, ICU stay, and TG18 grade. Results: A total of 331 patients with cholecystitis were enrolled in this study. The averageMDWs for TG18 grades 1, 2, and 3 were 20.21 +/- 3.99, 20.34 +/- 3.68, and 25.77 +/- 6.61, respectively. For patients with severe cholecystitis, the average MDW was 25.42 +/- 6.83. Using the Youden J statistic, we set a cutoff MDW of 21.6. Multivariate logistic regression revealed that patients with an MDW >= 21.6 had a higher risk of severe cholecystitis (odds ratio=4.94; 95% CI, 1.71-14.21; p=0.003). The Cox model revealed that patients with an MDW >= 21.6 were more likely to have a prolonged hospital stay. Conclusions: MDW is a reliable indicator of severe cholecystitis and prolonged length of stay. Additional MDW testing and a complete blood count may provide simple information for predicting severe cholecystitis early.

Automated summary

This study found that monocyte distribution width (MDW) is associated with the severity of cholecystitis, with higher MDW values indicating severe cholecystitis and prolonged hospital stay. Therefore, MDW testing and complete blood count can provide simple information for early prediction of severe cholecystitis.